Biofrontera Financial Overview
Biofrontera's market cap is currently €14.46M. The company's EPS TTM is €; its P/E ratio is -6.77; Biofrontera is scheduled to report earnings on May 28, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.